Don't want ads? Subscribe or login now.

D.C. Judge Axes Teva Challenge To Drug Price Program

By Gianna Ferrarin · November 21, 2025, 8:01 PM EST

A D.C. federal judge tossed a challenge by Teva Pharmaceuticals to the Medicare drug price negotiation program, marking the latest in a series of losses by drugmakers and trade groups seeking...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

TEVA PHARMACEUTICALS USA, INC. et al v. BECERRA et al

Case Number

1:25-cv-00113

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

January 15, 2025

Recent Articles By Gianna

November 18, 2025
Massage Therapist Prevails In Fla. Health Dept. License Saga
November 17, 2025
B. Braun Unit Inks $38.5M Deal To End FCA Knee Implant Case
November 17, 2025
No High Court Review For FDA Fast-Track Denial
November 11, 2025
A Novo Trial Win, AI Suicide Suits, and Humana v. ChenMed
November 05, 2025
Pharmacy Groups Urge 8th Circ. To Back Ark. PBM Limits
November 04, 2025
Meet The Attys Behind Drugmakers' Conn. Price Cap Suit
November 04, 2025
NY Court Splits On Emotional Damage From Fatal Birth Injury
October 31, 2025
Hawaii Judge Declares FDA's Mifepristone Regs Unlawful
October 28, 2025
4 Emergency Medical Care Rulings You Don't Want To Miss
October 22, 2025
NIH Sued For Access To Research On Trans Youth Care